Health In Tech Statistics
Total Valuation
Health In Tech has a market cap or net worth of $45.23 million. The enterprise value is $39.91 million.
Important Dates
The next estimated earnings date is Friday, August 15, 2025, before market open.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Health In Tech has 54.67 million shares outstanding. The number of shares has increased by 6.18% in one year.
| Current Share Class | 42.97M |
| Shares Outstanding | 54.67M |
| Shares Change (YoY) | +6.18% |
| Shares Change (QoQ) | +9.51% |
| Owned by Insiders (%) | 78.69% |
| Owned by Institutions (%) | 1.56% |
| Float | 11.65M |
Valuation Ratios
The trailing PE ratio is 45.20 and the forward PE ratio is 12.73.
| PE Ratio | 45.20 |
| Forward PE | 12.73 |
| PS Ratio | 1.88 |
| Forward PS | 2.07 |
| PB Ratio | 3.09 |
| P/TBV Ratio | 5.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.98 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 37.35 |
| EV / Sales | 1.78 |
| EV / EBITDA | n/a |
| EV / EBIT | 35.07 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.31 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | n/a |
| Interest Coverage | 3.45 |
Financial Efficiency
Return on equity (ROE) is 10.50% and return on invested capital (ROIC) is 6.29%.
| Return on Equity (ROE) | 10.50% |
| Return on Assets (ROA) | 4.48% |
| Return on Invested Capital (ROIC) | 6.29% |
| Return on Capital Employed (ROCE) | 7.81% |
| Revenue Per Employee | $279,762 |
| Profits Per Employee | $13,357 |
| Employee Count | 80 |
| Asset Turnover | 1.41 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health In Tech has paid $313,156 in taxes.
| Income Tax | 313,156 |
| Effective Tax Rate | 22.66% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 65.36 |
| Average Volume (20 Days) | 263,158 |
Short Selling Information
The latest short interest is 180,343, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 180,343 |
| Short Previous Month | 264,891 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 1.55% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Health In Tech had revenue of $22.38 million and earned $1.07 million in profits. Earnings per share was $0.02.
| Revenue | 22.38M |
| Gross Profit | 16.66M |
| Operating Income | 1.14M |
| Pretax Income | 2.61M |
| Net Income | 1.07M |
| EBITDA | n/a |
| EBIT | 1.14M |
| Earnings Per Share (EPS) | $0.02 |
Full Income StatementBalance Sheet
The company has $7.58 million in cash and $190,717 in debt, giving a net cash position of $7.38 million or $0.14 per share.
| Cash & Cash Equivalents | 7.58M |
| Total Debt | 190,717 |
| Net Cash | 7.38M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 14.16M |
| Book Value Per Share | 0.26 |
| Working Capital | 8.82M |
Full Balance SheetCash Flow
| Operating Cash Flow | 3.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 74.44%, with operating and profit margins of 5.09% and 4.77%.
| Gross Margin | 74.44% |
| Operating Margin | 5.09% |
| Pretax Margin | 6.17% |
| Profit Margin | 4.77% |
| EBITDA Margin | n/a |
| EBIT Margin | 5.09% |
| FCF Margin | n/a |
Dividends & Yields
Health In Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.18% |
| Shareholder Yield | -6.18% |
| Earnings Yield | 2.26% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Health In Tech is $2.50, which is 202.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.50 |
| Price Target Difference | 202.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health In Tech has an Altman Z-Score of 24.02 and a Piotroski F-Score of 5.
| Altman Z-Score | 24.02 |
| Piotroski F-Score | 5 |